Article
New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.
Antimicrobial agents and chemotherapy - 1 May 2012
Segala Elena, Sougakoff Wladimir, Nevejans-Chauffour Aurelie, Jarlier Vincent, Petrella Stephanie
Abstract excerpt
TMC207 is a new antituberculous drug belonging to the diarylquinoline class which very efficiently inhibits the ATP synthase of mycobacteria such as Mycobacterium tuberculosis, one of the most important pathogens in the world. In order to map the amino acid residues involved in the binding of the drug, we have selected in vitro TMC207-resistant mutants from M. tuberculosis and diverse atypical mycobacteria. Six...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
